Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

计划入组 195 人 · 首次发布于 2023 年 1 月 12 日

Orotracheal Intubation with the ORION Videolaryngoscope Versus the King Vision Videolaryngoscope in Adult Patients: ORION Trial

计划入组 50 人 · 首次发布于 2024 年 10 月 2 日

Real Life Effectiveness of Easyhaler (Orion)

计划入组 24,003 人 · 首次发布于 2014 年 1 月 29 日

GIPR(Orion)

Ghrelin targeting therapeutic (Orion Biotechnology)

Heart failure therapeutics(Orion Oyj)

Orion Corporation, Orion Pharma

Finland

SIMBEC RESEARCH LIMITED

United Kingdom

Orion Corporation

Finland

Simbec-Orion and Avance Clinical Form Strategic Global CRO Partnership to Enhance Clinical Trial Capabilities

Caidya and Simbec-Orion Unite to Form a Differentiated Global CRO Spanning First-in-Human to Registration

Orion Secures Exclusive License for Abzena's Cancer-Targeting Monoclonal Antibody